Effect of Pressurised Intraperitoneal Aerosol Chemotherapy on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 46
- 试验地点
- 1
- 主要终点
- Overall survival at 6 months
研究概览
简要总结
Pressurised intraperitoneal aerosol chemotherapy is a new surgical technique, developed for the treatment of initially unresectable peritoneal carcinomatosis. The objective of this study was to compare the results of PIPAC associated with systemic chemotherapy with those of systemic chemotherapy alone in patients with gastric peritoneal carcinomatosis without metastasis other than peritoneal, and WHO performance status <3.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 18 years or over
- •Patients with adenocarcinoma-type gastric non-resectable péritonéale carcinomatosis.
- •Patients without metastasis other than peritoneal.
- •WHO performance status <3
- •Patients treated either with PIPAC administered in alternation with systemic chemotherapy (PIPAC_CHEM) or by systemic chemotherapy alone (ONLY_CHEM)
- •Patient informed
排除标准
- •Patients opposed
研究组 & 干预措施
PIPAC CHEM
PIPAC associated with systemic chemotherapy
干预措施: PIPAC with systemic chemotherapy (Drug)
ONLY CHEM
systemic chemotherapy alone
干预措施: Systemic chemotherapy alone (Drug)
结局指标
主要结局
Overall survival at 6 months
时间窗: 6 months
Overall survival at 6 months from diagnosis of carcinomatosis
次要结局
- Duration of hospital stay(6 months)
- overall survival from the diagnosis of carcinomatosis and from the diagnosis of the primary tumour.(3 years)
研究者
Pr Catherine Arvieux
Professeur
Association Francaise de Chirurgie
